EDN1 and cardiac hypertrophy: In vitro models of cardiac hypertrophy have been developed to overcome some of these limitations, e.g. neonatal rat cardiomyocytes stimulated by α-adrenergic agonists or endothelin-1 [11], or, when cultured on silicone membranes, by phasic or tonic stretch [19].